Method for Producing Isoxazoline Carboxylic Acid Derivatives

The synthesis of isoxazoline carboxylic acid derivatives is optimized by reacting compound (II) with 'R 3 OMgHal' and a base, addressing low yields and purities in existing methods, achieving high purity and efficiency for industrial production.

JP2024544694APending Publication Date: 2024-12-03BAYER AG
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
JP2024534088
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-12-07
Filing Date
2022-12-01
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

Existing methods for synthesizing isoxazoline carboxylic acid derivatives yield insufficient results for industrial-scale production, with low yields and isomeric purities, necessitating laborious purification processes.

Method used

A method involving the reaction of a compound of general formula (II) with a combination of reagents including a reactive species 'R 3 OMgHal' (IV) and an additional base, under optimized conditions to form isoxazoline carboxylic acid derivatives of formula (I), enhancing diastereomeric ratios and enabling high yields and purity suitable for industrial synthesis.

Benefits of technology

The method achieves high yields and isomeric purity, allowing for efficient industrial-scale synthesis of isoxazoline carboxylic acid derivatives without the need for laborious purification, and can produce diastereomeric ratios up to 100:0 through optimized reaction conditions.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024544694000001
    Figure 2024544694000001
  • Figure 2024544694000002
    Figure 2024544694000002
  • Figure 2024544694000003
    Figure 2024544694000003
Patent Text Reader

Abstract

The present invention relates to a novel process for preparing isoxazoline carboxylic acid derivatives of formula (I).
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a novel process for preparing isoxazoline carboxylic acid derivatives of formula (I). [Background technology]

[0002] Isoxazoline carboxylic acid derivatives of general formula (I) are important precursors of active pesticide ingredients, such as the herbicides described in WO 2014 / 048882 and WO 2018 / 228985.

[0003] Prior art, such as Tetrahedron Letters, 1991, 6367-6370; Eur. J. Org. Chem. 2008, 5446-5460; Bull. Chem. Soc. Jpn. 1993, 2685, describes a number of cyclization methods for preparing isoxazoline carboxylic acid derivatives. Possible transition states of the cycloaddition are discussed. Yields and isomer ratios depending on reaction conditions are also disclosed.

[0004] When the compounds of the invention are obtained by one of the methods known from the literature, this results in yields and isomeric purity that are insufficient for industrial-scale synthesis. [Prior art documents] [Patent documents]

[0005] [Patent Document 1] International Publication No. 2014 / 048882 Brochure [Patent Document 2] International Publication No. 2018 / 228985 Brochure [Non-patent literature]

[0006] [Non-Patent Document 1] Tetrahedron Letters, 1991, 6367~6370 [Non-Patent Document 2] Eur.J.Org.Chem.2008, 5446~5460 [Non-Patent Document 3] Bull. Chem. Soc. Jpn. 1993, 2685 Summary of the Invention

[0007] It was therefore an object of the present invention to provide a process for the preparation of isoxazoline carboxylic acid derivatives of general formula (I) which is suitable for synthesis on an industrial scale, has high yields and isomeric purity, and as a result allows the elimination of laborious purification procedures.

[0008] The object of this invention is to provide an isoxazoline carboxylic acid derivative of the general formula (I) [ka] (In the formula, X 2 is H, C1-C4 alkyl, C1-C4 fluoroalkyl, C1-C4 fluoroalkoxy, C1-C4 alkoxy, fluorine, or CN; X 3 is H, C1-C4 alkyl, C1-C4 fluoroalkyl, C1-C4 fluoroalkoxy, C1-C4 alkoxy, fluorine, chlorine, or CN; X 4 is H, C1-C4 alkyl, C1-C4 fluoroalkyl, C1-C4 fluoroalkoxy, C1-C4 alkoxy, fluorine, or CN; X 5 is H, C1-C4 alkyl, C1-C4 fluoroalkyl, C1-C4 fluoroalkoxy, C1-C4 alkoxy, fluorine, chlorine, or CN; X 6 is H, C1-C4 alkyl, C1-C4 fluoroalkyl, C1-C4 fluoroalkoxy, C1-C4 alkoxy, fluorine, or CN; R 1 H, C1~C 12 -alkyl, unsubstituted benzyl or mono- or di-C1-C4 alkyl substituted benzyl; R 2is C1-C4-alkyl) A method for preparing Compounds of formula (II) [ka] (In the formula, X 2 ~X 6 has the definition given above, X 7 , X 8 , X 10 , X 11 are independently H or C1-C4-alkyl, X 9 is H, C1-C4-alkyl or N(C1-C4-alkyl)2) of, additional base, and 1 to 3.5 equivalents of the reactive species "R 3 OMgHal" (IV) (In the formula, R 3 is alkyl, unsubstituted or alkyl substituted benzyl; Hal is a halogen) Adding a combination of reagents that allows for the formation of Compound of formula (III) [ka] (In the formula, R 1 and R 2 has the definition given above) to obtain a compound of general formula (I).

[0009] Preferred definitions of the groups in the compounds of general formulae (I), (II) and (III) are as follows: X 2 is H, methyl, trifluoromethyl, difluoromethyl, difluoromethoxy, trifluoromethoxy, fluorine, methoxy, CN; X 3is H, methyl, trifluoromethyl, difluoromethyl, difluoromethoxy, trifluoromethoxy, fluorine, chlorine, methoxy, CN; X 4 is H, methyl, trifluoromethyl, difluoromethyl, difluoromethoxy, trifluoromethoxy, fluorine, methoxy, CN; X 5 is H, methyl, trifluoromethyl, difluoromethyl, difluoromethoxy, trifluoromethoxy, fluorine, chlorine, methoxy, CN; X 6 is H, methyl, trifluoromethyl, difluoromethyl, difluoromethoxy, trifluoromethoxy, fluorine, methoxy, CN; X 7 , X 8 , X 10 , X 11 are independently H, methyl, or ethyl; X 9 is H, methyl, ethyl or N(methyl)2, R 1 is H, C1-C4-alkyl, R 2 are methyl and ethyl.

[0010] Preferably, the compound of general formula (IV) is prepared by reacting the compound with the following combination of reagents: -R 4 MgHal and R 3 OH or -MgHal2 and R 3 OM or -MgHal2 and Mg(OR 3 )2 (In the formula, R 3 is C2~C 12 -alkyl, unsubstituted or C1-C4-alkyl substituted benzyl; Hal is a halogen, M is an alkali metal; R 4 is alkyl, unsubstituted aryl, substituted aryl, unsubstituted benzyl, substituted benzyl, allyl, vinyl) It is generated by one of the

[0011] Alternatively, the compound of general formula (IV) can be prepared by reacting the compound with the following combination of reagents: -R 5 MgHal and R 6 R 7 CO (In the formula, R 5 is C1-C6-alkyl, aryl, benzyl, R 6 , R 7 is H, C1-C6-alkyl, aryl) Definition of the resulting group produced by R 3 R 5 R 6 R 7 Corresponds to C.

[0012] Alternatively presented are the preferred radical definitions of the reagents for preparing the compounds of general formula (IV): R 5 is C1-C4-alkyl, phenyl, benzyl, p-tolyl; R 6 , R 7 is H, C1-C4-alkyl, phenyl.

[0013] Particularly preferred definitions of the radicals in the compounds of general formulae (I), (II) and (III) are as follows: X 2 is H, X 3 is H, methyl, trifluoromethyl, difluoromethyl, fluorine, chlorine, methoxy, CN; X 4 is fluorine, H, X 5 is H, methyl, trifluoromethyl, difluoromethyl, fluorine, chlorine, methoxy, CN; X 6 is H, X 7 , X 8 , X 11 are independently H, methyl, or ethyl; X 9 is H,N(methyl)2, X 10 is H, R 1 is H, methyl, ethyl, i-propyl, i-butyl, R 2 is methyl.

[0014] More preferably, the compound of general formula (IV) is prepared by the following combination of reagents: -R 4 MgHal and R 3 OH or -MgHal2 and R 3 OM or -MgHal2 and Mg(OR 3 )2 (In the formula, R 3 is C2-C8-alkyl, Hal is bromine, chlorine, M is an alkali metal; R 4 is C1-C8-alkyl, phenyl, benzyl, p-tolyl, vinyl) It is generated by one of the

[0015] Very particularly preferred definitions of the radicals in the compounds of the general formulae (I), (II) and (III) are as follows: X 2 is H, X 3 is H, fluorine, X 4 is H, fluorine, X 5 is H, fluorine, X 6 is H, X 8 is H, methyl, ethyl, X 7 , X 11 are independently H, methyl; X 9 , X 10 is H, R 1is H, methyl, i-propyl, i-butyl, R 2 is methyl.

[0016] Even more preferably, the compound of general formula (IV) is prepared by the following combination of reagents: -R 4 MgHal and R 3 OH or -MgHal2 and R 3 OM or -MgHal2 and Mg(OR 3 )2 (In the formula, R 3 is i-propyl, i-butyl, 2-butyl, Hal is bromine, chlorine, M is sodium, R 4 are methyl, ethyl, n-butyl, and i-propyl) It is generated by one of the

[0017] The most preferred definitions of the groups in the compounds of general formulae (I), (II) and (III) are as follows: X 2 is H, X 3 is fluorine, X 4 is H, X 5 is fluorine, X 6 is H, X 7 , X 8 , X 11 are independently H, methyl; X 9 , X 10 is H, R 1 is H, methyl, i-butyl, R 2 is methyl. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0018] definition Alkyl is a saturated linear or branched hydrocarbyl group having the number of carbon atoms specified in each case, e.g. C1-C such as methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, hexyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl and 1-ethyl-2-methylpropyl. 12 -alkyl.

[0019] Hal means halogen and is fluorine, chlorine, bromine or iodine. When this term is used in a group, Hal means a fluorine, chlorine, bromine or iodine atom.

[0020] Alkali metal means lithium, sodium or potassium.

[0021] Aryl means phenyl or naphthyl.

[0022] The compound of formula (I) may be in the form of an isomeric mixture. The desired diastereomeric excess is increased by optimizing the reaction conditions compared to the prior art. 1.8 to 2.2 equivalents of the reactant "R 3 OMgHal" (IV) is particularly advantageous.

[0023] When an (S)-alcohol is used, the major product is the (S,S)-diastereomer and the (R,S)-diastereomer is the second diastereomer. When an (R)-alcohol is used, the major product is the (R,R)-diastereomer and the (S,R)-diastereomer is the second diastereomer. When a (rac)-alcohol is used, the major product is the (S,S / R,R)-rac-diastereomer and the (S,R / R,S)-rac-diastereomer is the second diastereomer.

[0024] Compounds of formula (I) may be isolated as the corresponding esters or, after post-hydrolytic workup, as the carboxylic acids.

[0025] Through enrichment by crystallization, diastereomeric ratios of up to 100:0 can be achieved in compounds of formula (I). [ka]

[0026] The object is to provide a method for preparing an isoxazoline carboxylic acid derivative of formula (I), comprising reacting a compound of general formula (II) with an additional base and 1 to 3.5 equivalents of a reactive species "R 3 This is achieved by a method (Scheme 1) characterized in that a combination of reagents is added that allows the formation of "OMgHal" (IV) which reacts with the compound of formula (III) to give the compound of general formula (I).

[0027] 1.5 to 3.0 equivalents of the reactive species "R 3 The use of "OMgHal" (IV) is preferred.

[0028] The use of 0.05 to 3.0 equivalents of additional base (based on the compound of general formula (II)) is also preferred.

[0029] The use of 0.1 to 1.5 equivalents of additional base (based on the compound of general formula (II)) is particularly preferred.

[0030] The use of 0.2 to 1.0 equivalents of an additional base (based on the compound of general formula (II)) is quite particularly preferred.

[0031] The additional base is any base; tertiary amines, pyridines and amide bases are preferred. Particularly preferred bases are tertiary amines with N(C1-C4-alkyl)3 (two or three different alkyl substituents are preferably present): triethylamine [Et3N], tributylamine, diisopropylethylamine, cyclohexyldimethylamine [CyN(methyl)2], 2- and 3-picoline, methylpyridine, methylethylpyridine, ethylpyridine. Et3N and CyN(methyl)2 are very particularly preferred.

[0032] Other particularly preferred bases are amide bases such as N,N-dimethylformamide (DMF), N,N-diethylformamide (DEF), dimethylacetamide (DMAc), N,N-dibutylformamide (DBF) or N-methylpyrrolidone (NMP).

[0033] Also particularly preferred are combinations of tertiary amine bases or pyridine bases with amide bases.

[0034] Combinations of tertiary amine bases and amide bases are quite particularly preferred.

[0035] The addition of water may also be advantageous and may lead to further improvement of the diastereomeric ratio (dr). The use of up to 1.0 equivalent of water (based on the compound of general formula (II)) is preferred.

[0036] The cyclization is usually carried out within a temperature range of -25°C to 70°C, preferably 10°C to 30°C.

[0037] Furthermore, the cyclization is optionally carried out in the presence of a solvent or diluent or a mixture of solvents, preferably toluene, xylene, tetrahydrofuran (THF), isopropyl acetate (i-PrOAc), acetonitrile, methyl tert-butyl ether (MTBE), methyl-THF, ethyl acetate (EtOAc) or a mixture thereof in any ratio.

[0038] Compounds of general formula (III) are prepared via a two-step process and are known from the literature. The first step is the Baylis-Hillman reaction. The relevant literature references are Drewes, SE; Hoole, RFA [Synthetic Communications, 1985, Vol. 15, 12, pp. 1067-1074]. For the second step, the relevant literature reference is Nascimento et al. (2003, Tetrahedron Asymmetry 14, 311-311).

[0039] Compounds of the general formulae (II) and (III) are also known from WO 2018 / 228985. The preparation of compounds of formula (IIa) from compounds of formula (II) is known from Binenfeld, Zlatko et al. Glasnik Hemijskog Drustva Beograd (1966), 31(4-6), 243-50 and Daroszewski, J. et al. Pharmazie (1986), 41(10), 699-702.

[0040] Table 1 shows various possible combinations of reagents, however this selection is not exhaustive.

[0041] Working Example The present invention will be elucidated in detail by the following examples, but the present invention is not limited to these examples.

[0042] Analysis method The product 1 Characterized by 1 H NMR spectroscopy and / or LC-MS (liquid chromatography mass spectrometry).

[0043] NMR spectra were measured using a Bruker Avance 400 equipped with a flow probe head (volume 60 μl). In individual cases, NMR spectra were measured using a Bruker Avance II 600. For quantitative NMR (qNMR) measurements, methyl 3,5-dinitrobenzoate was used as an internal standard.

[0044] [Table 1]

[0045] [Table 2]

[0046] Example 3 (Reaction Procedure Type A) Under an argon atmosphere, 2 equivalents (eq) of 2-propylmagnesium chloride (4.00 ml, 2 mol / l in THF) are initially charged at 20° C. 2 equivalents of 2-propanol (0.61 ml) are added dropwise over 10 minutes with cooling (ice bath). Propane escapes (slight bubbling) and a white solid precipitates. After the addition is complete and gas evolution has ceased, the resulting suspension is stirred for 20 minutes at 20° C. Then, 1 equivalent of methyl 3-hydroxy-2-methylenebutanoate (0.49 ml, 99.8% by weight) is added at room temperature and stirring is continued for 15 minutes. The mixture becomes more fluid. Then, 1 equivalent of triethylamine (0.56 ml) is added dropwise over 5 minutes at room temperature with stirring. After stirring for another 15 min at room temperature, a solution of 3,5-difluoro-N-hydroxybenzenecarboximidoyl chloride in a solvent mixture of toluene / THF (4.14 g, 18.5 wt%) is added dropwise at about 15 °C by syringe pump together with an additional 1.5 equivalents of N,N-di-N-butylformamide (DBF) (1.10 ml). The addition time is 1 hour (h). The reaction mixture is then warmed to room temperature and stirred for another hour. Then, an HCl solution is added to the reaction mixture and extracted with ethyl acetate. The aqueous phase is extracted once more with ethyl acetate. The combined organic phases are concentrated under reduced pressure. An excess of aqueous sodium hydroxide solution is added to the residue and stirred at 65 °C. Once hydrolysis is complete, the reaction mixture is cooled to room temperature, acidified (pH 1-2) and extracted twice with ethyl acetate. The combined organic phases are concentrated under reduced pressure. After determining the content (qNMR), 0.90 g of product is present in the residue (83%). Diastereomeric ratio = 93:7 (HPLC).

[0047] Example 15 (Reaction Procedure Type B) Under an argon atmosphere, 2 equivalents (eq) of 2-propylmagnesium chloride (4.00 ml, 2 mol / l in THF) are initially charged at 20° C. 2 equivalents of 2-propanol (0.61 ml) are added dropwise over 10 minutes while cooling (ice bath). Propane escapes (slight bubbling) and a white solid precipitates. After the addition is complete and gas evolution has ceased, the resulting suspension is stirred for 20 minutes at 20° C. Then, 1 equivalent of methyl 3-hydroxy-2-methylenebutanoate (0.49 ml, 99.8% by weight) is added at room temperature and stirring is continued for 15 minutes. The mixture becomes more fluid. Then, 1 equivalent of N,N-dimethylcyclohexylamine (0.60 ml) is added dropwise over 5 minutes while stirring at room temperature. After stirring for a further 15 minutes at room temperature, 0.3 equivalents of DMF (92 μl) are added and the suspension is stirred for a further 10 minutes at room temperature and then cooled to about 15° C. Then, a solution of 3,5-difluoro-N-hydroxybenzenecarboximidoyl chloride in a solvent mixture of toluene / THF (3.33 g, 23.00 wt%) is added dropwise at about 15° C. by syringe pump together with an additional 0.3 equivalents of water (32 μl). The addition time is 1 hour (h). The reaction mixture is then warmed to room temperature and stirred for another hour. Then, an HCl solution is added to the reaction mixture and extracted with ethyl acetate. The aqueous phase is extracted once more with ethyl acetate. The combined organic phases are concentrated under reduced pressure. An excess of aqueous sodium hydroxide solution is added to the residue and stirred at 65° C. Once hydrolysis is complete, the reaction mixture is cooled to room temperature, acidified (pH 1-2) and extracted twice with ethyl acetate. The combined organic phases are concentrated under reduced pressure. After determining the content (qNMR), 0.89 g of product is present in the residue (82%). Diastereomeric ratio=94:6 (HPLC).

[0048] Example 19 (Reaction Procedure Type C) Under an argon atmosphere, 2 equivalents (eq) of methylmagnesium chloride (2.67 ml, 3 mol / l in THF) are initially charged at 0° C. (ice bath cooling). A solution of 2.075 equivalents of acetaldehyde in anhydrous THF (0.47 ml in 1.25 ml THF) is added dropwise at 0° C. with stirring over 10 minutes (min). A white solid precipitates during the addition. The suspension is stirred at 0° C. for a further 30 min and then warmed to room temperature (RT) over about 15 min. Then, 1 equivalent of methyl (3S)-3-hydroxy-2-methylenebutanoate (0.52 ml, 95.5% wt, 98.8% ee) is added at RT and stirring is continued for 15 min. The mixture becomes more fluid. Then, 1 equivalent of triethylamine (0.56 ml) is added dropwise over 5 min at RT with stirring. After stirring for another 15 min at room temperature, 0.3 equivalents of DMF (92 μl) are added and the suspension is stirred for another 10 min at room temperature and then cooled to about 15° C. Then, a solution of 3,5-difluoro-N-hydroxybenzenecarboximidoyl chloride in a solvent mixture of toluene / THF (2.58 g, 29.6 wt%) is added dropwise at about 15° C. by syringe pump with an additional 0.3 equivalents of water (22 μl). The addition time is 1 hour (h). The reaction mixture is then warmed to room temperature and stirred for another 1 h. Then, an HCl solution is added to the reaction mixture and extracted with ethyl acetate. The aqueous phase is extracted once more with ethyl acetate. The combined organic phases are concentrated under reduced pressure. An excess of aqueous sodium hydroxide solution is added to the residue and stirred at 65° C. Once hydrolysis is complete, the reaction mixture is cooled to room temperature, acidified (pH 1-2) and extracted twice with ethyl acetate. The combined organic phases are concentrated under reduced pressure. After determining the content (qNMR), 0.92 g of product is present in the residue (84%). Diastereomeric ratio = 93:7 (HPLC).

[0049] Example 20 6.79 g (51.2 mmol) of methyl (3S)-3-hydroxy-2-methylenebutanoate was dissolved in 650 ml of dichloromethane at room temperature under an argon atmosphere and isopropanol was added. The clear solution was cooled to 0° C. Then 156 ml (156 mmol) of EtMgBr (1M) in THF was slowly added dropwise (exothermic). The solution became cloudy. Then a solution of 10.00 g (52.2 mmol) of 3,5-difluoro-N-hydroxybenzimidoyl chloride in 100 ml of DCM was slowly added dropwise with stirring (15 min) and the mixture was gradually warmed to room temperature. The mixture turned a clear yellow color. TLC in EA / n-heptane 1:1 showed complete conversion after 30 min.

[0050] Post-processing: The solution was added to 1 L of a 1:1 mixture of 2N HCl and saturated NaCl solution, extracted twice with 400 ml of methylene chloride each time, dried over Na2SO4, filtered and concentrated. LCMS analysis of the crude product showed a diastereomeric ratio of the products of 86% to 14%. Silica gel chromatography (n-hep / EA) Fr.1m = lipophilic diastereomer 600mg (4.0%) 1 H NMR(CDCl3):1.10(d,3H,CHCH3),2.3(s br.,1H,OH),3.53(d,1H,CHH isoxazoline),3.72(d,1H,CHH isoxazoline),3.84b(s,3H,OCH3),4,34(q,1H,CHCH3),6.88(tt,1H,arom.H),7.22(m,2H,arom.H). Fr.2m = polar diastereomer 7700mg (51.7%) 1 H NMR(CDCl3):1.29(d,3H,CHCH3),2.10(d,1H,OH),3.57(d,1H,CHH isoxazoline),3.69(d,1H,CHH isoxazoline),3.84b(s,3H,OCH3),4,24(q,1H,CHCH3),6.88(tt,1H,arom.H),7.18(m,2H,arom.H).

Claims

1. Isoxazoline carboxylic acid derivatives of formula (I) [Formula 1] (In the formula, X 2 , H, C 1 ~C 4 Alkyl, C 1 ~C 4 Fluoroalkyl, C 1 ~C 4 Fluoroalkoxy, C 1 ~C 4 Alkoxy, fluorine, CN; X 3 , H, C 1 ~C 4 Alkyl, C 1 ~C 4 Fluoroalkyl, C 1 ~C 4 Fluoroalkoxy, C 1 ~C 4 Alkoxy, fluorine, chlorine, CN; X 4 , H, C 1 ~C 4 Alkyl, C 1 ~C 4 Fluoroalkyl, C 1 ~C 4 Fluoroalkoxy, C 1 ~C 4 Alkoxy, fluorine, CN; X 5 , H, C 1 ~C 4 Alkyl, C 1 ~C 4 Fluoroalkyl, C 1 ~C 4 Fluoroalkoxy, C 1 ~C 4 Alkoxy, fluorine, chlorine, CN; X 6 , H, C 1 ~C 4 Alkyl, C 1 ~C 4 Fluoroalkyl, C 1 ~C 4 Fluoroalkoxy, C 1 ~C 4 Alkoxy, fluorine, CN; R 1 , H, C 1 ~C 12 -alkyl, unsubstituted benzyl or mono- or di-C 1 ~C 4 is an alkyl substituted benzyl; R 2 is C 1 ~C 4 -alkyl) A method for preparing Compound of formula (II) [chemical 2] (In the formula, X 2 ~X 6 has the definition given above, X 7 , X 8 , X 10 , X 11 are independently H or C 1 ~C 4 - alkyl, X 9 , H, C 1 ~C 4 -Alkyl or N(C 1 ~C 4 -alkyl) 2 (It is) of, additional base, and 1 to 3.5 equivalents of reactive species “R 3 OMgHal" (IV) (In the formula, R 3 is alkyl, unsubstituted or alkyl substituted benzyl; Hal is a halogen. Adding a combination of reagents that allows for the formation of Compound of formula (III) [C3] (In the formula, R 1 and R 2 has the definition given above) to obtain a compound of general formula (I).

2. The definitions of the groups in the compounds of the general formulae (I), (II) and (III) are as follows: X 2 is H, methyl, trifluoromethyl, difluoromethyl, difluoromethoxy, trifluoromethoxy, fluorine, methoxy, CN; X 3 is H, methyl, trifluoromethyl, difluoromethyl, difluoromethoxy, trifluoromethoxy, fluorine, chlorine, methoxy, CN; X 4 is H, methyl, trifluoromethyl, difluoromethyl, difluoromethoxy, trifluoromethoxy, fluorine, methoxy, CN; X 5 is H, methyl, trifluoromethyl, difluoromethyl, difluoromethoxy, trifluoromethoxy, fluorine, chlorine, methoxy, CN; X 6 is H, methyl, trifluoromethyl, difluoromethyl, difluoromethoxy, trifluoromethoxy, fluorine, methoxy, CN; X 7 , X 8 , X 10 , X 11 are independently H, methyl, or ethyl; X 9 is H, methyl, ethyl or N(methyl) 2 and R 1 H, C 1 ~C 4 - alkyl, R 2 is methyl, ethyl, The method of claim 1.

3. The definitions of the groups in the compounds of the general formulae (I), (II) and (III) are as follows: X 2 is H, X 3is H, methyl, trifluoromethyl, difluoromethyl, fluorine, chlorine, methoxy, CN; X 4 is fluorine, H, X 5 is H, methyl, trifluoromethyl, difluoromethyl, fluorine, chlorine, methoxy, CN; X 6 is H, X 7 , X 8 , X 11 are independently H, methyl, or ethyl; X 9 H, N (methyl) 2 and X 10 is H, R 1 is H, methyl, ethyl, i-propyl, i-butyl, R 2 is methyl, 3. The method according to claim 1 or 2.

4. The definitions of the groups in the compounds of the general formulae (I), (II) and (III) are as follows: X 2 is H, X 3 is H, fluorine, X 4 is H, fluorine, X 5 is H, fluorine, X 6 is H, X 8 is H, methyl, ethyl, X 7 , X 11 are independently H, methyl; X 9 , X 10 is H, R 1 is H, methyl, i-propyl, i-butyl, R 2 is methyl, 4. The method according to any one of claims 1 to 3.

5. The definitions of the groups in the compounds of the general formulae (I), (II) and (III) are as follows: X 2 is H, X 3 is fluorine, X 4 is H, X 5 is fluorine, X 6 is H, X 7 , X 8 , X 11 are independently H, methyl; X 9 , X 10 is H, R 1 is H, methyl, i-butyl, R 2 is methyl, The method according to claim 1 or 4.

6. The definitions of the groups in the compound of the general formula (IIa) are as follows: X 7 , X 8 , X 10 , X 11 are independently H, methyl, or ethyl; X 9 is H, methyl, ethyl or N(methyl) 2 That is, 6. The method according to any one of claims 1 to 5.

7. The definitions of the groups in the compound of the general formula (IIa) are as follows: X 7 , X 11 is H, X 8 , X 10 are independently H, methyl, or ethyl; X 9 H, methyl, ethyl, N(methyl) 2 That is, 7. The method according to any one of claims 1 to 6.

8. The compound of general formula (IV) can be prepared by the following combination of reagents: -R 4 MgHal and R 3 OH or -MgHal 2 and R 3 OM or -MgHal 2 and Mg (OR 3 ) 2 (In the formula, R 3 is C 2 ~C 12 -Alkyl, unsubstituted or C 1 ~C 4 - alkyl substituted benzyl, Hal is a halogen, M is an alkali metal; R 4 is alkyl, unsubstituted aryl, substituted aryl, unsubstituted benzyl, substituted benzyl, allyl, vinyl) The method of any one of claims 1 to 7, wherein the method is produced by one of the following:

9. The compound of general formula (IV) can be prepared by the following combination of reagents: -R 4 MgHal and R 3 OH or -MgHal 2 and R 3 OM or -MgHal 2 and Mg (OR 3 ) 2 (In the formula, R 3 is C 2 ~C 8 - alkyl, Hal is bromine, chlorine, M is an alkali metal; R 4 is C 1 ~C 8-alkyl, phenyl, benzyl, p-tolyl, vinyl) The method of any one of claims 1 to 7, wherein the method is produced by one of the following:

10. The compound of general formula (IV) can be prepared by the following combination of reagents: -R 4 MgHal and R 3 OH or -MgHal 2 and R 3 OM or -MgHal 2 and Mg (OR 3 ) 2 (In the formula, R 3 is i-propyl, i-butyl, 2-butyl, Hal is bromine, chlorine, M is sodium, R 4 is methyl, ethyl, n-butyl, i-propyl) The method of any one of claims 1 to 7, wherein the method is produced by one of the following:

11. Based on the compound of general formula (II), 1.5 to 3.0 equivalents of the reactant "R 3 11. The method according to claim 1, characterized in that "OMgHal" (IV) is used.

12. 12. The process according to any one of claims 1 to 11, characterized in that 0.05 to 3.0 equivalents of additional base are used, based on the compound of general formula (II).

13. 12. The process according to claim 1, characterized in that 0.1 to 1.5 equivalents of additional base are used, based on the compound of general formula (II).

14. 12. The process according to any one of claims 1 to 11, characterized in that 0.2 to 1.0 equivalents of additional base are used, based on the compound of general formula (II).

15. The additional base is Et 3 N or CyN (methyl) 2 15. The method according to claim 1 , wherein

16. 16. The method according to any one of claims 1 to 15, characterized in that the solvent is toluene, xylene, tetrahydrofuran (THF), isopropyl acetate (i-PrOAc), acetonitrile, methyl tert-butyl ether (MTBE), methyl-THF, ethyl acetate (EtOAc) or a mixture thereof in any ratio.

17. The process according to any one of claims 1 to 16, characterized in that the reaction is carried out at a temperature between -25°C and 70°C.

18. 17. The process according to any one of claims 1 to 16, characterized in that the reaction is carried out at a temperature between 10°C and 30°C.

19. 19. The process according to any one of claims 1 to 18, characterized in that the base used is a tertiary amine base or a combination of a pyridine base and an amide base.

20. 20. The process according to any one of claims 1 to 19, characterized in that a maximum of 1.0 equivalent of water (based on the compound of general formula (II)) is used.

21. 21. The process according to any one of claims 1 to 20, characterized in that the diastereomeric ratio is increased by an additional crystallization step.

22. The compound of the general formula (IV) can be reacted with the following reagent combination via Grignard reaction: -R 5 MgHal and R 6 R 7 CO (In the formula, R 5 is C 1 ~C 6 - alkyl, aryl, benzyl, R 6 , R 7 , H, C 1 ~C 6 -alkyl, aryl) The definition of the resulting group is R 3 R 5 R 6 R 7 9. The method according to claim 1 , wherein the method corresponds to C.

Citation Information

Patent Citations

  • Diastereoselective synthesis method of isoxazole compounds

    JP2016530293A

  • Herbicidal 3-phenylisoxazoline-5-carboxamides of tetrahydro- and dihydrofurancarboxylic acids and esters

    JP2020523346A

  • Herbicidal and fungicidal 5-oxy-substituted 3-phenylisoxazoline-5-carboxamides and 5-oxy-substituted 3-phenylisoxazoline-5-thioamides

    WO2014048882A1

  • Herbicidally active 3-phenylisoxazoline-5-carboxamides of tetrahydro and dihydrofuran carboxylic acids and esters

    WO2018228985A1